Oral Fenretinide in Biochemically Recurrent Prostate Cancer: A California Cancer Consortium Phase II Trial-Reference-Cited by-同舟云学术

Oral Fenretinide in Biochemically Recurrent Prostate Cancer: A California Cancer Consortium Phase II Trial

Published:2009-01 Issue:1 Volume:7 Page:43-50
ISSN:1558-7673
Container-title:Clinical Genitourinary Cancer
language:en
Short-container-title:Clinical Genitourinary Cancer

Author:

Cheung Eric,Pinski Jacek,Dorff Tanya,Groshen Susan,Quinn David I.,Reynolds C. Patrick,Maurer Barry J.,Lara Primo N.,Tsao-Wei Denice D.,Twardowski Przemyslaw,Chatta Gurkamal,McNamara Mark,Gandara David R.

Publisher

Elsevier BV

Subject

Urology,Oncology

Reference63 articles.

1. Cancer statistics;Jemal;Cancer J Clin,2007

2. Differential effects of N-(4-hydroxyphenyl)retinamide retinoic acid on neuroblastoma cells: apoptosis versus differentiation;Ponzoni;Cancer Res,1995

3. Neuroblastoma cell apoptosis induced by the synthetic retinoid N-(4-hydroxyphenyl)retinamide;Di Vinci;Int J Cancer,1994

4. N-(4hydroxyphenyl)retinamide: a potent inducer of apoptosis in human neuroblastoma cells;Mariotti;J Natl Cancer Inst,1994

5. Synergistic cytotoxicity in solid tumor cell lines between N-(4-hydroxyphenyl)retinamide and modulators of ceramide metabolism;Maurer;J Natl Cancer Inst,2000

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Attempts to Improve Lipophilic Drugs’ Solubility and Bioavailability: A Focus on Fenretinide;Pharmaceutics;2024-04-24

2. Targeting lipid metabolism in metastatic prostate cancer;Therapeutic Advances in Medical Oncology;2023-01

3. Sphingolipid Metabolism in Cancer: Potential Therapeutic Target;Handbook of Cancer and Immunology;2023

4. Fenretinide in Cancer and Neurological Disease: A Two-Face Janus Molecule;International Journal of Molecular Sciences;2022-07-04

5. Nutritional and surgical aspects in prostate disorders;Critical Reviews in Food Science and Nutrition;2022-01-12